337 related articles for article (PubMed ID: 8841302)
21. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Quinn GE; Dobson V; Kivlin J; Kaufman LM; Repka MX; Reynolds JD; Gordon RA; Hardy RJ; Tung B; Stone RA
Ophthalmology; 1998 Jul; 105(7):1292-300. PubMed ID: 9663236
[TBL] [Abstract][Full Text] [Related]
22. Grating visual acuity in eyes with retinal residua of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Dobson V; Quinn GE; Saunders RA; Spencer R; Davis BR; Risser J; Palmer EA
Arch Ophthalmol; 1995 Sep; 113(9):1172-7. PubMed ID: 7661752
[TBL] [Abstract][Full Text] [Related]
23. Prediction of visual function in eyes with mild to moderate posterior pole residua of retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Reynolds J; Dobson V; Quinn GE; Gilbert WS; Tung B; Robertson J; Flynn JT
Arch Ophthalmol; 1993 Aug; 111(8):1050-6. PubMed ID: 8352687
[TBL] [Abstract][Full Text] [Related]
24. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991.
Johnson L; Quinn GE; Abbasi S; Gerdes J; Bowen FW; Bhutani V
J Pediatr; 1995 Oct; 127(4):632-9. PubMed ID: 7562291
[TBL] [Abstract][Full Text] [Related]
25. Late visual field changes following cryotherapy for retinopathy of prematurity stage 3.
Kremer I; Nissenkorn I; Lusky M; Yassur Y
Br J Ophthalmol; 1995 Mar; 79(3):267-9. PubMed ID: 7703208
[TBL] [Abstract][Full Text] [Related]
26. Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years. Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Msall ME; Phelps DL; DiGaudio KM; Dobson V; Tung B; McClead RE; Quinn GE; Reynolds JD; Hardy RJ; Palmer EA
Pediatrics; 2000 Nov; 106(5):998-1005. PubMed ID: 11061766
[TBL] [Abstract][Full Text] [Related]
27. Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.
Good WV;
Trans Am Ophthalmol Soc; 2004; 102():233-48; discussion 248-50. PubMed ID: 15747762
[TBL] [Abstract][Full Text] [Related]
28. Acuity card assessment of visual function in the cryotherapy for retinopathy of prematurity trial.
Dobson V; Quinn GE; Biglan AW; Tung B; Flynn JT; Palmer EA
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1702-8. PubMed ID: 2211019
[TBL] [Abstract][Full Text] [Related]
29. The outcome of retinopathy of prematurity: screening for retinopathy of prematurity using an outcome predictive program.
Onofrey CB; Feuer WJ; Flynn JT
Ophthalmology; 2001 Jan; 108(1):27-34; discussion 34-5. PubMed ID: 11150259
[TBL] [Abstract][Full Text] [Related]
30. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity.
Connolly BP; McNamara JA; Sharma S; Regillo CD; Tasman W
Ophthalmology; 1998 Sep; 105(9):1628-31. PubMed ID: 9754168
[TBL] [Abstract][Full Text] [Related]
31. Retinal detachment of regressed retinopathy of prematurity in children aged 2 to 15 years.
Park KH; Hwang JM; Choi MY; Yu YS; Chung H
Retina; 2004 Jun; 24(3):368-75. PubMed ID: 15187658
[TBL] [Abstract][Full Text] [Related]
32. The natural ocular outcome of premature birth and retinopathy. Status at 1 year. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Arch Ophthalmol; 1994 Jul; 112(7):903-12. PubMed ID: 8031269
[TBL] [Abstract][Full Text] [Related]
33. Severe visual impairment in children with mild or moderate retinal residua following regressed threshold retinopathy of prematurity.
Siatkowski RM; Dobson V; Quinn GE; Summers CG; Palmer EA; Tung B
J AAPOS; 2007 Apr; 11(2):148-152. PubMed ID: 17416324
[TBL] [Abstract][Full Text] [Related]
34. Risk analysis of prethreshold retinopathy of prematurity.
Hardy RJ; Palmer EA; Dobson V; Summers CG; Phelps DL; Quinn GE; Good WV; Tung B;
Arch Ophthalmol; 2003 Dec; 121(12):1697-701. PubMed ID: 14662587
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of cryotherapy for retinopathy of prematurity.
Wachtmeister L; Algvere P; Gjötterberg M
Acta Ophthalmol (Copenh); 1992 Jun; 70(3):389-94. PubMed ID: 1636404
[TBL] [Abstract][Full Text] [Related]
36. Visual acuity in infants after vitrectomy for severe retinopathy of prematurity.
Quinn GE; Dobson V; Barr CC; Davis BR; Flynn JT; Palmer EA; Robertson J; Trese MT
Ophthalmology; 1991 Jan; 98(1):5-13. PubMed ID: 2023732
[TBL] [Abstract][Full Text] [Related]
37. Grating visual acuity results in the early treatment for retinopathy of prematurity study.
; Dobson V; Quinn GE; Summers CG; Hardy RJ; Tung B; Good WV
Arch Ophthalmol; 2011 Jul; 129(7):840-6. PubMed ID: 21746974
[TBL] [Abstract][Full Text] [Related]
38. Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial.
Quinn GE; Dobson V; Siatkowski R; Hardy RJ; Kivlin J; Palmer EA; Phelps DL; Repka MX; Summers CG; Tung B; Chan W;
Ophthalmology; 2001 Feb; 108(2):343-7. PubMed ID: 11158812
[TBL] [Abstract][Full Text] [Related]
39. [Use of cryotherapy in retinopathy of prematurity].
Starzycka M; Kobylarz J; Starzycka-Bigaj E
Klin Oczna; 1996 Jan; 98(1):33-6. PubMed ID: 9019572
[TBL] [Abstract][Full Text] [Related]
40. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome--structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group.
Arch Ophthalmol; 1990 Oct; 108(10):1408-16. PubMed ID: 2222274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
